Gad Soffer, EVP & Chief Strategy Officer at Atara Biotherapeutics, Inc. (ATRA), sold 2,500 shares at $20.00 ($50K) on 2017-03-10, disclosed to the SEC on 2017-03-13.
Open-market sale of $50k ATRA by EVP & Chief Strategy Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ATRA | SELL | 2017-08-17 | $141K | — | Filing → |
| ATRA | SELL | 2017-05-17 | $192K | — | Filing → |
| ATRA | SELL | 2017-02-16 | $334K | — | Filing → |